Stock Analiz

Novo Nordisk A S (NVO) earnings: date, estimates and history

Price $41.72 · data as of November 16, 2026

Next earnings report

Next reportNot announced yet
Quarterending December 31, 2026
EPS estimate—
Revenue estimate—
Expected EPS growth−19.3%

The date appears here once Novo Nordisk A S confirms it, usually two to four weeks before the report.

Track record

Beat EPS estimates4 of 5
Average surprise+10.6%
Average move on report day±5.0%

Novo Nordisk A S beat the consensus earnings estimate in 4 of its last 5 reports, by +10.6% on average. On report days the stock moved 5.0% on average, up or down.

Earnings history

ReportedEPS estimateEPS actualSurpriseRevenueRevenue growthStock move
November 4, 2026
Sep/2026
$4.62$5.79+25.3%——+0.3%
August 4, 2026
Jun/2026
$4.98$6.18+24.0%——−5.4%
May 6, 2026
Mar/2026
$6.96$6.63−4.8%——+2.1%
February 4, 2026
Dec/2025
$5.90$6.04+2.3%——−13.8%
November 5, 2025
Sep/2025
$4.24$4.50+6.0%——−3.6%

EPS as compared with analyst estimates (adjusted EPS). Revenue growth is against the same quarter a year earlier. Stock move: change on the first trading day after the report.

Frequently asked questions

When is Novo Nordisk A S’s next earnings date?

Novo Nordisk A S has not confirmed its next report date yet. Its last report was on November 4, 2026.

Did Novo Nordisk A S beat earnings last quarter?

Yes, it reported EPS of $5.79 on November 4, 2026 against an estimate of $4.62 (a +25.3% surprise), and the stock moved +0.3% the next trading day.

Report dates and estimates from analyst consensus data; results from company reports. Updated daily. Not investment advice. Earnings calendar